feed,title,long_url,short_url
Benzinga,"Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition",https://benzinga.com/general/biotech/24/01/36599560/novartis-retreats-from-cytokinetics-deal-dashing-hopes-for-multi-billion-dollar-acquisition,https://da.gd/1Z6jO
